Advances in current and emerging therapeutics for gestational trophoblast malignancies
Author:
- 28 December 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Orphan Drugs
- Vol. 7 (1) , 27-36
Abstract
Introduction: Gestational Trophoblastic Neoplasia (GTN) are a group of rare malignancies arising from the cells of conception. GTN was the first metastatic cancer to be cured with chemotherapy and nearly all of today’s patients can expect to be cured with modern drug treatment. Based on the experience of the GTN unit at Charing Cross Hospital in London, the historical, current and forthcoming management of this biologically unique malignancy will be reviewed. Areas covered: This review will cover the classification and epidemiology of molar pregnancies, gestational choriocarcinoma and PSTT/ETT. The current approaches to management for low, high and ultra high-risk patients and the recent impact of immunotherapy for chemotherapy resistant disease are discussed. Expert opinion: GTN form a group of rare but highly curable malignancies. The unique biology of the cancer cells makes them extremely sensitive to chemotherapy and also to immunotherapy and overall cure rates approach 100%. Optimising the organisation of care for this rare group of malignancies increases the cure rates and minimise adverse outcomes. Current immunotherapy research may allow patients to access curative treatment with lower toxicity and reduced long term side effects compared to prolonged treatment with cytotoxic drugs.Keywords
This publication has 42 references indexed in Scilit:
- The proliferation rate paradox in antimitotic chemotherapyMolecular Biology of the Cell, 2012
- HLA-G: a human pregnancy-related immunomodulatorCurrent Opinion in Pharmacology, 2009
- Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)Annals of Oncology, 2008
- A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasiaBritish Journal of Cancer, 2007
- Persistent trophoblast disease following partial molar pregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2006
- Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significanceGynecologic Oncology, 2006
- Routine pre‐evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral centerUltrasound in Obstetrics & Gynecology, 2005
- Presentation and management of choriocarcinoma after nonmolar pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- The histopathology of trophoblastic tumoursJournal of Clinical Pathology, 1976
- Treatment of Choriocarcinoma with a Combination of Cytotoxic DrugsBMJ, 1960